Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
| Revenue (Most Recent Fiscal Year) | $2.11B |
| Net Income (Most Recent Fiscal Year) | $404.39M |
| PE Ratio (Current Year Earnings Estimate) | 33.81 |
| PE Ratio (Trailing 12 Months) | 35.16 |
| PEG Ratio (Long Term Growth Estimate) | 2.98 |
| Price to Sales Ratio (Trailing 12 Months) | 5.95 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 77.09 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 33.90 |
| Pre-Tax Margin (Trailing 12 Months) | 22.20% |
| Net Margin (Trailing 12 Months) | 18.74% |
| Return on Equity (Trailing 12 Months) | 67.66% |
| Return on Assets (Trailing 12 Months) | 21.86% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.43 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.43 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $6.14 |
| Earnings per Share (Most Recent Fiscal Quarter) | $3.10 |
| Earnings per Share (Most Recent Fiscal Year) | $12.63 |
| Diluted Earnings per Share (Trailing 12 Months) | $13.45 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 28.09M |
| Free Float | 22.39M |
| Market Capitalization | $13.29B |
| Average Volume (Last 20 Days) | 0.34M |
| Beta (Past 60 Months) | 1.42 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 20.30% |
| Percentage Held By Institutions (Latest 13F Reports) | 77.98% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |